Skip to main content

Table 5 Pre-defined outcome measures in terms of health care costs analyzed by different statistical approaches regarding the comparison “Triple always” versus “Triple not always”

From: Effects of triple therapy on disease burden in patients of GOLD groups C and D: results from the observational COPD cohort COSYCONET

Annual health care costs (€)

Univariate

Linear Regression

Optimal full matching

IPW

Total direct costs

Estimate

2843.1

1419.4

1025

1526.9

95%CI

608.99; 5077.15

-853.5; 3680.6

-1476.0; 3526.0

-752.6; 3806.4

p value

0.012

0.222

0.423

0.19

Medication costs

Estimate

977.8

806.8

748.2

808

95%CI

519.51; 1436.17;

328.9; 1282.2

234.9; 1261.5

305.9; 1310.2

p value

< 0.001

0.001

0.005

0.002

Respiratory medication costs

Estimate

592.3

532.1

525.3

535.0

95%CI

466.53; 717.99

411.1; 652.5

395.0; 655.5

400.9; 669.1

p value

< 0.001

9.21e-16

< 0.001

< 0.001

Other medication costs

Estimate

386.4

275.5

223.5

273.7

95%CI

36.11; 808.88

-174.6; 723.4

-247.9; 694.9

-187.5; 734.9

p value

0.073

0.231

0.354

0.246

Outpatient costs

Estimate

36.8

2.6

17.5

-7.7

95%CI

106.84; 180.49

-151.9; 156.3

-151.3; 186.3

-167.8; 152.3

p value

0.614

0.973

0.839

0.925

Inpatient costs

Estimate

1126.3

418.4

82.6

318.1

95%CI

40.98; 2211.65

-673.9; 1505.2

-1271.4; 1436.6

-876.1; 1512.3

p value

0.042

0.454

0.905

0.602

Rehabilitation costs

Estimate

113.4

7.04

-39.4

23.9

95%CI

87.04; 313.88

-199.9; 213.0

-304.6; 225.8

-195.4; 243.1

p value

0.266

0.947

0.771

0.831

Physiotherapy

Estimate

48.1

49.6

36.84

48.1

95%CI

6.904; 89.280

3.5; 95.4

-14.4; 88.0

-1.7; 94.6

p value

0.022

0.036

0.16

0.043

  1. IPW Inverse Probability Weighting. All variables shown were first tested in univariate analyses and then in the multivariable analyses shown in the other three columns, always using the set of predictors shown in Table 1